Swiss Regenerative Medicine & Cellular Therapy company introduces its 'Change, with Lab Dom' global stakeholder campaign
LAS VEGAS, Dec. 8, 2011 /PRNewswire-Asia/ -- Laboratoires Dom AVMM (Suisse) Inc. (Lab Dom) -- one of the world's leading regenerative medicine and cellular therapy companies -- has made its official North American debut as a Platinum Elite sponsor of the '19th Annual World Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies' (A4M Las Vegas) being held from 8-10 December in Las Vegas, USA.
"Our presence at this exhibition signifies our commitment to a path of rapid dynamic expansion," said Mike Chan, co-founder of Lab Dom.
"For the first time in our company history, we will be opening our doors to preferred partners and associates from the North and South American regions to join us at this pivotal time."
Specialising in the formulation and distribution of precursor stem cell, organ-specific cell, placental extract and botanical cell therapy products, Lab Dom has achieved a solid reputation for excellence over the last 20 years across the Western Europe and Asia-Pacific regions.
The company is now poised to embark on a phase of dynamic global expansion aimed at increasing its presence in China, the European Union and the Middle East, as well as the vital North and South American markets.
"To support this planned expansion, we have introduced a targeted stakeholder campaign 'Change, with Lab Dom' which will service our stakeholders and customers around the globe at a world's best-practice level," explained Michael Lodge, Chief Executive Officer, Lab Dom.
The 'Change, with Lab Dom' stakeholder campaign incorporates an innovative distribution model and channel activation program, and will be introduced to the North and South American markets during the exhibition at an exclusive networking event hosted by Lab Dom on the evening of Thursday 8 December.
"We are a family company, with family values, servicing a very human business," said Michelle Wong, co-founder of Lab Dom.
"We are in the business of providing the opportunity for change for humankind, and an opportunity to increase the quality of life itself. We would like to open the doors and invite potential international partners to join us in this incredibly dynamic phase of Lab Dom's evolution."
With global headquarters in Geneva, Switzerland and Asia-Pacific regional headquarters in Kota Kinabalu, Malaysia, Lab Dom is committed to continual innovative research and development in the rapidly expanding fields of regenerative medicine and anti-aging cellular therapy fields.
"A new industry era is dawning, and Lab Dom has always been a well-respected pioneer at the forefront of change," continued Mike Chan.
"The time is right for the evolution our company, and we invite preferred partners and associates in the North and South American regions to join us as we strengthen our position in these markets.
"To share the bounty of our science, and to grow with our new business."
From 2012, Lab Dom will be introducing new levels of scientific and corporate governance, security, anti-fraud and counterfeit protection to take the industry lead on developments in the regenerative medicine and cellular therapy industry.
For more information visit www.labdom.com and www.changewithlabdom.com
About Lab Dom
Laboratoires Dom AVMM (Suisse) Inc., (LabDom) is a Swiss held and globally headquartered regenerative medicine and cellular therapy company, with regional Asia-Pacific headquarters in Kota Kinabalu, Malaysia.
Founded in 1998 by entrepreneurial husband and wife team, Mike Chan and Michelle Wong, Lab Dom is a world-leader in precursor stem cell, placental extract, organ-specific and botanical cell product manufacturing and distribution, providing revitalisation therapies to combat aging and chronic degenerative diseases.
With state-of-the-art laboratories and highly professional medical staff based in Switzerland, as well as the European Union and Asia-Pacific, Lab Dom is committed to innovative research and development in the rapidly expanding fields of regenerative medicine and antiaging cellular therapy fields.
Lab Dom is currently embarking on a dynamic global expansion phase, aimed at increasing its presence in China, the European Union, the Middle East as well as the North and South American markets.
For media inquiries contact:
Andrew Tham
Message Manager
Lab Dom
Mobile: +60-16-8105490
Tel: +60-88-766266
email: andrew@labdom.com
